{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T16:00:46Z","timestamp":1787760046743,"version":"build-2784847793"},"reference-count":70,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2008,5,1]],"date-time":"2008-05-01T00:00:00Z","timestamp":1209600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,5,1]],"date-time":"2008-05-01T00:00:00Z","timestamp":1209600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain, Behavior, and Immunity"],"published-print":{"date-parts":[[2008,5]]},"DOI":"10.1016\/j.bbi.2007.12.013","type":"journal-article","created":{"date-parts":[[2008,2,22]],"date-time":"2008-02-22T11:56:41Z","timestamp":1203681401000},"page":"606-613","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":80,"title":["Buprenorphine and methadone maintenance treatment of heroin addicts preserves immune function"],"prefix":"10.1016","volume":"22","author":[{"given":"Paola","family":"Sacerdote","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Franchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilberto","family":"Gerra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Leccese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto E.","family":"Panerai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Somaini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbi.2007.12.013_bib1","first-page":"317","article-title":"Opioids, immunology and host defence of intravenous drug abusers","volume":"20","author":"Alonzo","year":"2002","journal-title":"Infect. Dis. Clin. North Am."},{"key":"10.1016\/j.bbi.2007.12.013_bib2","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/0196-9781(94)90028-0","article-title":"Beta-endorphin content in HIV infected Hut 78 cell line and in peripheral lymphocytes from HIV positive subjects","volume":"15","author":"Barcellini","year":"1994","journal-title":"Peptides"},{"key":"10.1016\/j.bbi.2007.12.013_bib3","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.molimm.2003.10.005","article-title":"Innate immunity, an overview","volume":"40","author":"Beutler","year":"2004","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.bbi.2007.12.013_bib4","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1210\/jc.2004-0929","article-title":"Plasma testorene and sexual function in men receiving buprenorphine maintenance for opioid dependence","volume":"90","author":"Bliesener","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bbi.2007.12.013_bib5","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jneuroim.2007.05.007","article-title":"Comparative analysis of mu opioid receptor in immune end neuronal cells","volume":"1\u20132","author":"Borner","year":"2007","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.bbi.2007.12.013_bib6","doi-asserted-by":"crossref","first-page":"5839","DOI":"10.4049\/jimmunol.179.9.5839","article-title":"A functionally coupled mu3-opiate receptor\/nitric oxide regulatory pathway in human multi-lineage progenitor cells","volume":"179","author":"Cadet","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbi.2007.12.013_bib7","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.intimp.2004.01.011","article-title":"Buprenorphine produces naltrexone reversible alterations of immune status","volume":"4","author":"Carrigan","year":"2004","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.bbi.2007.12.013_bib8","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/0952-7915(95)80050-6","article-title":"The Th1\/Th2 balance in autoimmunity","volume":"7","author":"Charlton","year":"1994","journal-title":"Curr. Op. Immunol."},{"key":"10.1016\/j.bbi.2007.12.013_bib9","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S1521-6616(03)00177-3","article-title":"No detrimental effect from chronic exposure to buprenorphine on corticosteroid-binding globulin and corticosensitive immune parameters","volume":"109","author":"D\u2019Elia","year":"2003","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.bbi.2007.12.013_bib10","series-title":"SCL-90-R: administration, scoring, and procedures: manual 1","author":"Derogatis","year":"1977"},{"key":"10.1016\/j.bbi.2007.12.013_bib11","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0165-5728(97)00224-5","article-title":"Opiates as potential cofactors in progression of HIV-1 infections to AIDS","volume":"83","author":"Donahoe","year":"1998","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.bbi.2007.12.013_bib12","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jneuroim.2003.10.011","article-title":"Multiple ways that drug abuse might influence AIDS progression: clues from a monkey model","volume":"147","author":"Donahoe","year":"2004","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.bbi.2007.12.013_bib13","first-page":"175","article-title":"Consequences of opiate-dependency in a monkey model of AIDS","volume":"373","author":"Donahoe","year":"1993","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.bbi.2007.12.013_bib14","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/0090-1229(86)90109-1","article-title":"Coordinate and independent effects of heroin, cocaine, and alcohol abuse on T-cell E rosette formation and antigenic marker expression","volume":"41","author":"Donahoe","year":"1986","journal-title":"Clin. Immunol. Immunopathol."},{"key":"10.1016\/j.bbi.2007.12.013_bib15","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S0165-5728(97)00219-1","article-title":"Opioid modulation of immune responses: effects on phagocyte and lymphoid cell populations","volume":"83","author":"Eisenstein","year":"1998","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.bbi.2007.12.013_bib16","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3109\/10826088009040004","article-title":"Opiate and human chromosome alterations","volume":"15","author":"Falek","year":"1980","journal-title":"Int. J. Addict."},{"key":"10.1016\/j.bbi.2007.12.013_bib17","series-title":"Intervista clinica Strutturata per il DSM-III-R","author":"Fava","year":"1993"},{"key":"10.1016\/j.bbi.2007.12.013_bib18","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/S0022-3565(25)12317-3","article-title":"Assessment of the involvement of central nervous system and peripheral opioid receptors in the immunomodulatory effects of acute morphine treatment in rats","volume":"276","author":"Fecho","year":"1996","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bbi.2007.12.013_bib19","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.bbi.2007.01.001","article-title":"Buprenorphine ameliorates the effect of surgery on hypothalamus pituitary adrenal axis, natural killer cell activity and metastatic colonization in rats in comparison with morphine or fentanyl treatment","volume":"21","author":"Franchi","year":"2007","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2007.12.013_bib20","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1128\/CMR.16.2.209-219.2003","article-title":"Microbial infections, immunomodulation and drug of abuse","volume":"16","author":"Friedman","year":"2003","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.bbi.2007.12.013_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0740-5472(03)00031-X","article-title":"Long-term methadone maintenance effectiveness: psychosocial and pharmacological variables","volume":"25","author":"Gerra","year":"2003","journal-title":"J. Subst. Abuse Treat"},{"key":"10.1016\/j.bbi.2007.12.013_bib22","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.drugalcdep.2003.11.017","article-title":"Buprenorphine versus methadone for opioid dependence: predictor variables for treatment outcome","volume":"75","author":"Gerra","year":"2004","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.bbi.2007.12.013_bib23","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.psychres.2006.02.013","article-title":"Experimentally induced aggressiveness in heroin-dependent patients treated with buprenorphine: comparison of patients receiving methadone and healthy subjects","volume":"149","author":"Gerra","year":"2007","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.bbi.2007.12.013_bib24","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0162-3109(00)00198-3","article-title":"Differential effects of buprenorphine and morphine on immune and neuroendocrine functions following acute administration in the rat mesencephalon periacqueductal gray","volume":"48","author":"Gomez-Flores","year":"2000","journal-title":"Immunopharmacology"},{"key":"10.1016\/j.bbi.2007.12.013_bib25","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/ni1004-971","article-title":"The interface between innate and adaptive immunity","volume":"5","author":"Hoebe","year":"2004","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.bbi.2007.12.013_bib26","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1086\/433175","article-title":"The role of substance abuse in HIV disease progression: reconciling differences from laboratory and epidemiologic investigations","volume":"41","author":"Kapadia","year":"2005","journal-title":"Clin. Inft. Dis."},{"key":"10.1016\/j.bbi.2007.12.013_bib27","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.bbi.2006.11.010","article-title":"Protein hormones and immunity","volume":"21","author":"Kelley","year":"2007","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2007.12.013_bib28","series-title":"Addictive States","first-page":"205","article-title":"Rational for maintenance pharmacotherapy of opiate dependence","author":"Kreek","year":"1992"},{"key":"10.1016\/j.bbi.2007.12.013_bib29","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1749-6632.2001.tb03557.x","article-title":"Drug addictions: molecular and cellular endpoints","volume":"937","author":"Kreek","year":"2001","journal-title":"Ann. NY Acad. Sci."},{"key":"10.1016\/j.bbi.2007.12.013_bib30","first-page":"487","article-title":"Long-term pharmacotherapy for opiate addiction: opioid agonists","volume":"118","author":"Kreek","year":"1996"},{"key":"10.1016\/j.bbi.2007.12.013_bib31","article-title":"The role of transcription factor 1 and YY1 in proximal promoter region in initiation of transcription of the mu opioid receptor gene in human lymphocytes","author":"Li","year":"2007","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.bbi.2007.12.013_bib32","doi-asserted-by":"crossref","first-page":"5769","DOI":"10.1073\/pnas.76.11.5769","volume":"76","author":"Madden","year":"1979","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbi.2007.12.013_bib33","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0376-8716(00)00183-6","article-title":"The morphine-binding site on human activated T-cells is not related to the mu opioid receptor","volume":"1","author":"Madden","year":"2001","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.bbi.2007.12.013_bib34","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1189\/jlb.0406237","article-title":"Differential involvement of relb in morphine-induced modulation of chemotaxis NO and cytokine production in murine macrophages and lymphocytes","volume":"81","author":"Martucci","year":"2007","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.bbi.2007.12.013_bib35","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.pain.2004.04.020","article-title":"Chronic fentanyl or buprenorphine infusion in the mouse: similar analgesic profile but different effects on immune responses","volume":"110","author":"Martucci","year":"2004","journal-title":"Pain"},{"key":"10.1016\/j.bbi.2007.12.013_bib36","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0376-8716(00)00181-2","article-title":"Opioids, opioid receptors and the immune response","volume":"62","author":"McCarthy","year":"2001","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.bbi.2007.12.013_bib37","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1360-0443.1993.tb00809.x","article-title":"The effects of methadone on immune function among injecting drug users: a review","volume":"88","author":"McLachlan","year":"1993","journal-title":"Addiction"},{"key":"10.1016\/j.bbi.2007.12.013_bib38","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.4049\/jimmunol.125.6.2539","article-title":"Alteration of T and null lymphocyte frequencies in the peripheral blood of human opiate addicts: in vivo evidence for opiate receptor sites on T lymphocytes","volume":"125","author":"McDonough","year":"1980","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbi.2007.12.013_bib39","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/0167-5699(96)80606-2","article-title":"The expanding universe of T-cell subsets; Th1, Th2 and more","volume":"17","author":"Mosman","year":"1996","journal-title":"Immunol. Today"},{"key":"10.1016\/j.bbi.2007.12.013_bib40","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S0149-2918(02)80065-0","article-title":"Controlled clinical trial to assess the response of recent heroin abusers with chronic hepatitis C virus infection to treatment with interferon alpha-n2b","volume":"24","author":"Neri","year":"2002","journal-title":"Clin. Ther."},{"key":"10.1016\/j.bbi.2007.12.013_bib41","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1007\/s00213-005-2239-x","article-title":"Randomized clinical trial to compare the effects of metadone and buprenorphine on the immune system in drug abusers","volume":"179","author":"Neri","year":"2005","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bbi.2007.12.013_bib42","first-page":"74","article-title":"Immune response in addicts with chronic hepatitis C treated with interferon and ribavirine","volume":"22","author":"Neri","year":"2007","journal-title":"Hepathology"},{"key":"10.1016\/j.bbi.2007.12.013_bib43","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/S0022-3565(25)22252-2","article-title":"Natural killer cell activity and lymphocyte subsets in parenteral heroin abusers and long-term methadone maintenance patients","volume":"250","author":"Novick","year":"1989","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bbi.2007.12.013_bib44","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0192-0561(00)00023-0","article-title":"Pharmacokinetics and cytokine production in heroin and morphine-treated mice","volume":"22","author":"Pacifici","year":"2000","journal-title":"Int. J. Immunopharmacol."},{"key":"10.1016\/j.bbi.2007.12.013_bib45","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0006-2952(93)90508-T","article-title":"Mechanism of morphine-induced immunomodulation","volume":"46","author":"Peterson","year":"1993","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbi.2007.12.013_bib46","series-title":"Structured Interview for Personality Disorders, revised version","author":"Pfohl","year":"1989"},{"key":"10.1016\/j.bbi.2007.12.013_bib47","series-title":"Buprenorphine the unique opioid analgesic","article-title":"Buprenorphine for opioid dependence","author":"Preston","year":"2005"},{"key":"10.1016\/j.bbi.2007.12.013_bib48","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1189\/jlb.0304123","article-title":"Splenic macrophages and B cells mediate immunosuppression following withdrawal from morphine","volume":"78","author":"Rahim","year":"2005","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.bbi.2007.12.013_bib49","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1016\/S1567-5769(01)00128-X","article-title":"Administration of mu-kappa-or delta2-receptor agonists via osmotic minipumps suppresses murine splenic antibody responses","volume":"1","author":"Rahim","year":"2001","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.bbi.2007.12.013_bib50","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S0165-5728(03)00273-X","article-title":"Withdrawal from morphine in mice suppresses splenic macrophage function cytokine production and costimulatory molecules","volume":"144","author":"Rahim","year":"2003","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.bbi.2007.12.013_bib51","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.drugalcdep.2006.05.013","article-title":"Impaired cytokine production and suppresses lymphocyte proliferation activity in HCV-infected cocaine and heroin (speedball users)","volume":"85","author":"Rios-Olivares","year":"2006","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.bbi.2007.12.013_bib52","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/S0165-5728(97)00216-6","article-title":"Opiates and infections","volume":"83","author":"Risdahl","year":"1998","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.bbi.2007.12.013_bib53","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1146\/annurev.iy.12.040194.001303","article-title":"Lymphokine production by human T cell in disease states","volume":"12","author":"Romagnani","year":"1994","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.bbi.2007.12.013_bib54","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jneuroim.2003.10.016","article-title":"Chronic morphine treatment differentiates T helper cells to Th2 effector cells by modulating transcription factors GATA 3 and T-bet","volume":"147","author":"Roy","year":"2004","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.bbi.2007.12.013_bib55","first-page":"6361","article-title":"Morphine induces CD4+ T cell IL-4 expression through an adenyl cyclase mechanism independent of the protein kinase","volume":"175","author":"Roy","year":"2005","journal-title":"A pathway"},{"key":"10.1016\/j.bbi.2007.12.013_bib56","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/sj.bjp.0701138","article-title":"Antinociceptive and immunosuppressive effects of opiate drugs: a structure-related activity study","volume":"121","author":"Sacerdote","year":"1997","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bbi.2007.12.013_bib57","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1097\/00000539-200006000-00028","article-title":"Effect of tramadol and morphine on immune responses and pain after surgery in cancer patients","volume":"90","author":"Sacerdote","year":"2000","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.bbi.2007.12.013_bib58","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1182\/blood.V95.6.2031","article-title":"The opioid antagonist naloxone induces a shift from type 1 cytokine pattern to type 2 cytokine pattern in BALB\/CJ mice","volume":"95","author":"Sacerdote","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.bbi.2007.12.013_bib59","first-page":"106","article-title":"Experimental evidence for immunomodulatory effect of opioids","author":"Sacerdote","year":"2001"},{"key":"10.1016\/j.bbi.2007.12.013_bib60","doi-asserted-by":"crossref","first-page":"s9","DOI":"10.1191\/0269216306pm1124oa","article-title":"Opioids and the Immune system","volume":"20","author":"Sacerdote","year":"2006","journal-title":"Palliative Med."},{"key":"10.1016\/j.bbi.2007.12.013_bib61","series-title":"Structured Clinical Interview According to DSM-III-R","author":"Spitzer","year":"1990"},{"key":"10.1016\/j.bbi.2007.12.013_bib62","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.bbi.2005.02.002","article-title":"Multiple opioid receptors on immune cells modulate intracellular signaling","volume":"20","author":"Sharp","year":"2004","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2007.12.013_bib63","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/342082a0","article-title":"Interleukin-2 dependent autocrine proliferation in T-cells development","volume":"342","author":"Toribio","year":"1989","journal-title":"Nature"},{"key":"10.1016\/j.bbi.2007.12.013_bib64","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/0192-0561(85)90049-9","article-title":"Morphine and methadone impact on human phagocytic physiology","volume":"7","author":"Tubaro","year":"1985","journal-title":"Int. J. Immunopharmacol."},{"key":"10.1016\/j.bbi.2007.12.013_bib65","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s00281-006-0045-0","article-title":"Injecting drugs of abuse and immunity: implication for HIV vaccine testing and efficacy","volume":"28","author":"Ugen","year":"2007","journal-title":"Springfer Semin. Immun."},{"key":"10.1016\/j.bbi.2007.12.013_bib66","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1097\/01.mjt.0000132250.95650.85","article-title":"Opioid therapy and immunosuppression","volume":"11","author":"Vallejo","year":"2004","journal-title":"Am. J. Therapeut."},{"key":"10.1016\/j.bbi.2007.12.013_bib67","doi-asserted-by":"crossref","first-page":"426","DOI":"10.4049\/jimmunol.174.1.426","article-title":"Morphine impairs host innate immune response and increases susceptibility to Streptococcus pneumoniae lung infection","volume":"174","author":"Wang","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbi.2007.12.013_bib68","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/S0002-9440(10)61220-5","article-title":"Morphine withdrawal enhances hepatitis C virus replicon expression","volume":"167","author":"Wang","year":"2005","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbi.2007.12.013_bib69","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1097\/00000542-199509000-00008","article-title":"Morphine inhibits spontaneous and cytokine enhanced natural killer cell cytotoxicity in volunteers","volume":"83","author":"Yeager","year":"1996","journal-title":"Anesthesiology"},{"key":"10.1016\/j.bbi.2007.12.013_bib70","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/BF03020942","article-title":"Intrathecal morphine suppresses NK activity following abdominal surgery","volume":"47","author":"Yokota","year":"2000","journal-title":"Can J. Anaesth."}],"container-title":["Brain, Behavior, and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159108000299?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159108000299?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:19:25Z","timestamp":1760167165000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889159108000299"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5]]},"references-count":70,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,5]]}},"alternative-id":["S0889159108000299"],"URL":"https:\/\/doi.org\/10.1016\/j.bbi.2007.12.013","relation":{},"ISSN":["0889-1591"],"issn-type":[{"value":"0889-1591","type":"print"}],"subject":[],"published":{"date-parts":[[2008,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Buprenorphine and methadone maintenance treatment of heroin addicts preserves immune function","name":"articletitle","label":"Article Title"},{"value":"Brain, Behavior, and Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbi.2007.12.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}